Tag Archives: Drug

FDA undercuts $375,000 drug in surprise move

The FDA announced Monday that it was approving a separate drug for pediatric patients with a rare, painful neuromuscular disease called Lambert-Eaton myasthenic syndrome, also known as LEMS. The disease weakens and fatigues muscles, causing agonizing pain to the point at which patients struggle to walk. The move sparked celebration in the LEMS community and… Read More »